1-7 of 7
Feng Pan
Close
Sort by
Journal Articles

Demonstration That Loss of TET2 Impairs DNA Mismatch Repair Resulting in Clonally Restricted Genomic Instability

Dongxu Jiang, Feng Pan, Yihong Guan, Xiaorong Gu, Naomi Kawashima, Divya Jyoti Singh, Danai Dima, Guangbo Qu, Edward F Greenberg, Valeria Visconte, Omar Mian, Mingjiang Xu, Jaroslaw P. Maciejewski, Babal K. Jha
Journal: Blood
Blood (2022) 140 (Supplement 1): 1989–1990.
https://doi.org/10.1182/blood-2022-169467
Published: 2022
Journal Articles

TET2 Loss Accelerates Leukemogenesis By Disrupting Mismatch Repair Proteins

Ashwin Kishtagari, MBBS, Yihong Guan, PhD, Cassandra M Kerr, MS, Hassan Awada, MD, Jibran Durrani, Edward F Greenberg, MD, Xiaorong Gu, PhD, Feng Pan, PhD, Valeria Visconte, PhD, Dewen You, PhD, Guangbo Qu, PhD, Amy C Graham, BS, MS, Bartlomiej P. Przychodzen, Thomas Laframboise, PhD, Hideki Makishima, MD PhD, Daniel Gackowski, PhD, Ryszard Ólinski, Professor, Yu-Wei Cheng, PhD, Mikkael A. Sekeres, MD MS, Mingjiang Xu, MD PhD, Babal K. Jha, PhD, Jaroslaw P. Maciejewski, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1200.
https://doi.org/10.1182/blood-2019-132005
Published: 2019
Journal Articles

TET2 and MSH6: A Novel Role for MMR in the Pathogenesis of Myeloid Malignancies

Edward F Greenberg, MD, Cassandra M. Hirsch, BS, Feng Pan, PhD, Babal K Jha, PhD, Yihong Guan, PhD, Valeria Visconte, PhD, Dewen You, PhD, Guangbo Qu, PhD, Amy Graham, Bartlomiej P. Przychodzen, MSc, Thomas Laframboise, PhD, Hideki Makishima, MD PhD, Daniel Gackowski, PhD, Ryszard Ólinski, Professor, Yu-Wei Cheng, PhD, Mikkael A. Sekeres, MD MS, Mingjiang Xu, MDPhD, Jaroslaw P. Maciejewski, PhD MD FACP
Journal: Blood
Blood (2017) 130 (Supplement 1): 1668.
https://doi.org/10.1182/blood.V130.Suppl_1.1668.1668
Published: 2017
Journal Articles

Combined Loss of Tet1 and Tet2 Promotes B-Cell, but Not Myeloid Malignancies in Mice

Zhigang Zhao, MDPhD, Lin Li, PhD, Meelad Dawlaty, PhD, Feng Pan, PhD, Zhe Li, PhD, Yuan Zhou, PhD, Hui Shi, MD PhD, Shi Chen, MD PhD, Ophelia Weeks, PhD, Weiping Yuan, PhD, Hongyu Ni, PhD, Feng-Chun Yang, MD PhD, Rudolph Jaenisch, PhD, Peng Jin, MDPhD, Mingjiang Xu, MDPhD
Journal: Blood
Blood (2015) 126 (23): 3650.
https://doi.org/10.1182/blood.V126.23.3650.3650
Published: 2015
Journal Articles

Evaluation of Ibrutinib in Treatment of Mantle Cell Lymphoma: A Treatment Comparison Using a Simulation Model

Siyang Peng, Feng Pan, Sonja Sorensen, Emily Dorman, Yingxin Xu, Rachel Sallum, Maren Gaudig, Nishan Sengupta, PhD, Mark Wildgust, Steve Sun
Journal: Blood
Blood (2014) 124 (21): 2596.
https://doi.org/10.1182/blood.V124.21.2596.2596
Published: 2014
Journal Articles

Comparative Evaluation of Ibrutinib in Treatment of Chronic Lymphocytic Leukemia Using Simulation Modeling

Siyang Peng, Feng Pan, Sonja Sorensen, Emily Dorman, Yingxin Xu, Rachel Sallum, Maren Gaudig, Nishan Sengupta, PhD, Mark Wildgust, Steve Sun
Journal: Blood
Blood (2014) 124 (21): 1299.
https://doi.org/10.1182/blood.V124.21.1299.1299
Published: 2014
Journal Articles

Loss of Asxl1 leads to myelodysplastic syndrome–like disease in mice

Jiapeng Wang, Zhaomin Li, Yongzheng He, Feng Pan, Shi Chen, Steven Rhodes, Lihn Nguyen, Jin Yuan, Li Jiang, Xianlin Yang, Ophelia Weeks, Ziyue Liu, Jiehao Zhou, Hongyu Ni, Chen-Leng Cai, Mingjiang Xu, Feng-Chun Yang
Journal: Blood
Blood (2014) 123 (4): 541–553.
https://doi.org/10.1182/blood-2013-05-500272
Published: 2014
Includes: Supplemental data